K08-CA128925/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2009	1
2010	1
2012	1
2015	1
2025	0

Page 1

Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma.

Goldsmith KC, Gross M, Peirce S, Luyindula D, Liu X, Vu A, Sliozberg M, Guo R, Zhao H, Reynolds CP, Hogarty MD. Goldsmith KC, et al. Cancer Res. 2012 May 15;72(10):2565-77. doi: 10.1158/0008-5472.CAN-11-3603. Cancer Res. 2012. PMID: 22589275 Free PMC article.

BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists.

Goldsmith KC, Lestini BJ, Gross M, Ip L, Bhumbla A, Zhang X, Zhao H, Liu X, Hogarty MD. Goldsmith KC, et al. Cell Death Differ. 2010 May;17(5):872-82. doi: 10.1038/cdd.2009.171. Epub 2009 Nov 6. Cell Death Differ. 2010. PMID: 19893570 Free PMC article.

EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.

Nalluri S, Peirce SK, Tanos R, Abdella HA, Karmali D, Hogarty MD, Goldsmith KC. Nalluri S, et al. Cancer Biol Ther. 2015;16(2):276-86. doi: 10.1080/15384047.2014.1002333. Cancer Biol Ther. 2015. PMID: 25756510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year